Detalhe da pesquisa
1.
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
Proc Natl Acad Sci U S A
; 119(15): e2120787119, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385357
2.
Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single-centre retrospective study.
Br J Haematol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706448
3.
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Br J Haematol
; 204(3): 861-870, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939390
4.
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis.
Hematol Oncol
; 42(2): e3260, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415873
5.
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).
Proc Natl Acad Sci U S A
; 118(6)2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495363
6.
New insights into the clinical characteristics of SETD2-mutated acute myeloid leukaemia.
Br J Haematol
; 202(1): 111-115, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038274
7.
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia.
Br J Haematol
; 193(6): 1096-1104, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764511
8.
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.
Am J Hematol
; 96(3): 312-319, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306218
9.
Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60â¯years and has lower toxicities: Comparison with low-dose chemotherapy.
Blood Cells Mol Dis
; 77: 88-94, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005752
10.
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
BMC Infect Dis
; 19(1): 471, 2019 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138134
11.
Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single-centre retrospective analysis.
Br J Haematol
; 201(3): 568-572, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863709
12.
Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy.
Hematol Oncol
; 2018 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29862538
13.
Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia.
Ann Hematol
; 96(11): 1793-1800, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823055
14.
A case of multiple recurrence of Clostridium difficile infection with severe hematochezia in an immunocompromised host.
Anaerobe
; 42: 31-32, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377777
15.
PML-RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy-free postremission approach: A multiple institution experience.
Hematol Oncol
; 38(4): 618-621, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602127
16.
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
Ann Hematol
; 94(11): 1829-37, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26294332
17.
Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia.
Am J Hematol
; 95(7): E184-E186, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242976
18.
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Hematol Oncol
; 32(1): 40-6, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23963734
19.
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
Ann Hematol
; 93(6): 941-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24408159
20.
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.
Lancet Oncol
; 14(7): 599-608, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23664707